SpringerLink
Log in

Surgical Management of Proliferative Diabetic Retinopathy

  • Living reference work entry
  • First Online:
Albert and Jakobiec's Principles and Practice of Ophthalmology

  • 61 Accesses

Abstract

Treating patients with severe nonproliferative diabetic retinopathy or early proliferative diabetic retinopathy with panretinal photocoagulation and/or injections of anti-vascular endothelial growth factor may stabilize progression of retinopathy. However, despite such attempts at intervention and depending on the severity of disease at initial presentation as well as its progression, there are patients who will require surgical intervention. Advances in vitreoretinal surgery have made it possible to improve outcomes in eyes with advanced proliferative diabetic retinopathy that were once considered inoperable. Current indications for surgery include chronic or recurrent unilateral vitreous hemorrhage, premacular subhyaloidal hemorrhage, bilateral vitreous hemorrhage, tractional retinal detachment, and neovascular glaucoma. A proper and thorough evaluation during the initial encounter allows for the surgeon to set appropriate goals for the surgery and the patient’s expectations of the surgical outcome. The goals of surgery for PDR include removal of vitreous opacities, specifically hemorrhage, dissection of fibrovascular tissue to relieve traction on the posterior pole, reattachment of the tractional and/or rhegmatogenous retinal detachment, and prevention of recurrent proliferative disease by means of completion of panretinal photocoagulation. If these goals are accomplished, the retina should reattach and recurrence of proliferative disease should be minimal. However, postoperative complications such as advancement of cataract, recurrent vitreous hemorrhage, macular edema, rhegmatogenous retinal detachment, and glaucoma can and do occur. A successful surgical outcome for these patients requires a comprehensive evaluation preoperatively, proper preoperative medical management, appropriate counseling, and meticulous surgical intervention accompanied by detailed postoperative care and good patient compliance.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  1. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.

    Article  CAS  PubMed  Google Scholar 

  2. Kempen JH, O’Colmain BJ, Leske MC, Haffner SM, Klein R, Moss SE, et al. The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol. 2004;122(4):552–63.

    Article  PubMed  Google Scholar 

  3. The Diabetic Retinopathy Study Research Group. Preliminary report on effects of photocoagulation therapy. Am J Ophthalmol. 1976;81(4):383–96.

    Google Scholar 

  4. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology. 1991;98(5 Suppl):766–85.

    Google Scholar 

  5. Gross JG, Glassman AR, Liu D, Sun JK, Antoszyk AN, Baker CW, et al. Five-year outcomes of panretinal photocoagulation vs intravitreous Ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial. JAMA Ophthalmol. 2018;136(10):1138–48.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Wykoff CC, Eichenbaum DA, Roth DB, Hill L, Fung AE, Haskova Z. Ranibizumab induces regression of diabetic retinopathy in Most patients at high risk of progression to proliferative diabetic retinopathy. Ophthalmol Retina. 2018;2(10):997–1009.

    Article  PubMed  Google Scholar 

  7. Flynn HW Jr, Chew EY, Simons BD, Barton FB, Remaley NA, Ferris FL 3rd. Pars plana vitrectomy in the early treatment diabetic retinopathy study. ETDRS report number 17. The early treatment diabetic retinopathy study research group. Ophthalmology. 1992;99(9):1351–7.

    Article  PubMed  Google Scholar 

  8. Michels RG. Vitrectomy for complications of diabetic retinopathy. Arch Ophthalmol. 1978;96(2):237–46.

    Article  CAS  PubMed  Google Scholar 

  9. Aaberg TM. Clinical results in vitrectomy for diabetic traction retinal detachment. Am J Ophthalmol. 1979;88(2):246–53.

    Article  CAS  PubMed  Google Scholar 

  10. Gupta B, Sivaprasad S, Wong R, Laidlaw A, Jackson TL, McHugh D, et al. Visual and anatomical outcomes following vitrectomy for complications of diabetic retinopathy: the DRIVE UK study. Eye (Lond). 2012;26(4):510–6.

    Article  CAS  Google Scholar 

  11. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Four-year results of a randomized trial: diabetic retinopathy vitrectomy study report 5. Arch Ophthalmol. 1990;108(7):958–64.

    Google Scholar 

  12. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy. Two-year results of a randomized trial. Diabetic retinopathy vitrectomy study report 2. Arch Ophthalmol. 1985;103(11):1644–52.

    Google Scholar 

  13. The Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial – diabetic retinopathy vitrectomy study report 3. Ophthalmology. 1988;95(10):1307–20.

    Google Scholar 

  14. Parikh RN, Traband A, Kolomeyer AM, VanderBeek BL, Kim BJ, Maguire AM, et al. Intravitreal Bevacizumab for the treatment of vitreous hemorrhage due to proliferative diabetic retinopathy. Am J Ophthalmol. 2017;176:194–202.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Huang YH, Yeh PT, Chen MS, Yang CH, Yang CM. Intravitreal bevacizumab and panretinal photocoagulation for proliferative diabetic retinopathy associated with vitreous hemorrhage. Retina. 2009;29(8):1134–40.

    Article  PubMed  Google Scholar 

  16. Arevalo JF, Maia M, Flynn HW Jr, Saravia M, Avery RL, Wu L, et al. Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy. Br J Ophthalmol. 2008;92(2):213–6.

    Article  CAS  PubMed  Google Scholar 

  17. Genovesi-Ebert F, Rizzo S, Chiellini S, Di bartolo E, Marabotti A, Nardi M. Reliability of standardized echography before vitreoretinal surgery for proliferative diabetic retinopathy. Ophthalmologica. 1998;212(Suppl 1):91–2.

    PubMed  Google Scholar 

  18. Obeid A, Gao X, Ali FS, Talcott KE, Aderman CM, Hyman L, et al. Loss to follow-up in patients with proliferative diabetic retinopathy after panretinal photocoagulation or intravitreal anti-VEGF injections. Ophthalmology. 2018;125(9):1386–92.

    Article  PubMed  Google Scholar 

  19. Obeid A, Su D, Patel SN, Uhr JH, Borkar D, Gao X, et al. Outcomes of eyes lost to follow-up with proliferative diabetic retinopathy that received panretinal photocoagulation versus intravitreal anti-vascular endothelial growth factor. Ophthalmology. 2019;126(3):407–13.

    Article  PubMed  Google Scholar 

  20. O’Hanley GP, Canny CL. Diabetic dense premacular hemorrhage. A possible indication for prompt vitrectomy. Ophthalmology. 1985;92(4):507–11.

    Article  PubMed  Google Scholar 

  21. Storey PP, Ter-Zakarian A, Philander SA, Olmos de Koo L, George M, Humayun MS, et al. Visual and anatomical outcomes after diabetic traction and traction-Rhegmatogenous retinal detachment repair. Retina. 2018;38(10):1913–9.

    Article  PubMed  Google Scholar 

  22. Dikopf MS, Patel KH, Setlur VJ, Lim JI. Surgical outcomes of 25-gauge pars plana vitrectomy for diabetic tractional retinal detachment. Eye (Lond). 2015;29(9):1213–9.

    Article  CAS  Google Scholar 

  23. Rahimy E, Pitcher JD 3rd, Gee CJ, Kreiger AE, Schwartz SD, Hubschman JP. Diabetic tractional retinal detachment repair by vitreoretinal fellows in a county health system. Retina. 2015;35(2):303–9.

    Article  PubMed  Google Scholar 

  24. Thompson JT, de Bustros S, Michels RG, Rice TA. Results and prognostic factors in vitrectomy for diabetic traction retinal detachment of the macula. Arch Ophthalmol. 1987;105(4):497–502.

    Article  CAS  PubMed  Google Scholar 

  25. Williams DF, Williams GA, Hartz A, Mieler WF, Abrams GW, Aaberg TM. Results of vitrectomy for diabetic traction retinal detachments using the en bloc excision technique. Ophthalmology. 1989;96(6):752–8.

    Article  CAS  PubMed  Google Scholar 

  26. Charles S, Flinn CE. The natural history of diabetic extramacular traction retinal detachment. Arch Ophthalmol. 1981;99(1):66–8.

    Article  CAS  PubMed  Google Scholar 

  27. Shah VA, Brown JS, Mahmoud TH. Correlation of outer retinal microstucture and foveal thickness with visual acuity after pars plana vitrectomy for complications of proliferative diabetic retinopathy. Retina. 2012;32(9):1775–80.

    Article  PubMed  Google Scholar 

  28. Brown JS, Mahmoud TH. Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy. Retina. 2011;31(10):1983–7.

    Article  PubMed  Google Scholar 

  29. Dayani PN, Grand MG. Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Arch Ophthalmol. 2006;124(11):1558–65.

    Article  CAS  PubMed  Google Scholar 

  30. Grand MG, Walia HS. Hemorrhagic risk of vitreoretinal surgery in patients maintained on novel oral anticoagulant therapy. Retina. 2016;36(2):299–304.

    Article  CAS  PubMed  Google Scholar 

  31. Castillo J, Aleman I, Rush SW, Rush RB. Preoperative Bevacizumab administration in proliferative diabetic retinopathy patients undergoing vitrectomy: a randomized and controlled trial comparing interval variation. Am J Ophthalmol. 2017;183:1–10.

    Article  CAS  PubMed  Google Scholar 

  32. Chen E, Park CH. Use of intravitreal bevacizumab as a preoperative adjunct for tractional retinal detachment repair in severe proliferative diabetic retinopathy. Retina. 2006;26(6):699–700.

    Article  PubMed  Google Scholar 

  33. daLucena D d R, Ribeiro JA, Costa RA, Barbosa JC, Scott IU, de Figueiredo-Pontes LL, et al. Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study). Br J Ophthalmol. 2009;93(5):688–91.

    Article  CAS  Google Scholar 

  34. Demir M, Oba E, Can E, Kara O, Cinar S. Effect of Bevacizumab injection before vitrectomy on intravitreal hemorrhage in pseudophakic patients with proliferative diabetic retinopathy. Ophthalmol Eye Dis. 2013;5:11–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. El-Sabagh HA, Abdelghaffar W, Labib AM, Mateo C, Hashem TM, Al-Tamimi DM, et al. Preoperative intravitreal bevacizumab use as an adjuvant to diabetic vitrectomy: histopathologic findings and clinical implications. Ophthalmology. 2011;118(4):636–41.

    Article  PubMed  Google Scholar 

  36. Feng J, Li B, Wen J, Jiang Y. Preoperative timing of intravitreal Bevacizumab injection for proliferative diabetic retinopathy patients. Ophthalmic Res. 2018;60(4):250–7.

    Article  CAS  PubMed  Google Scholar 

  37. Gandhi JS, Tan LT, Pearce I, Charles SJ. Bevacizumab (Avastin) as a surgical adjunct in diabetic vitrectomy for fibrovascular disease. Eye (Lond). 2009;23(3):742–3.

    Article  CAS  Google Scholar 

  38. Ishikawa K, Honda S, Tsukahara Y, Negi A. Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy. Eye (Lond). 2009;23(1):108–11.

    Article  CAS  Google Scholar 

  39. Modarres M, Nazari H, Falavarjani KG, Naseripour M, Hashemi M, Parvaresh MM. Intravitreal injection of bevacizumab before vitrectomy for proliferative diabetic retinopathy. Eur J Ophthalmol. 2009;19(5):848–52.

    Article  PubMed  Google Scholar 

  40. Cheema RA, Mushtaq J, Cheema MA. Role of residual vitreous cortex removal in prevention of postoperative vitreous hemorrhage in diabetic vitrectomy. Int Ophthalmol. 2010;30(2):137–42.

    Article  PubMed  Google Scholar 

  41. Steinmetz RL, Grizzard WS, Hammer ME. Vitrectomy for diabetic traction retinal detachment using the multiport illumination system. Ophthalmology. 2002;109(12):2303–7.

    Article  PubMed  Google Scholar 

  42. Fortun JA, Hubbard GB 3rd. New viscodissection instrument for use with microincisional vitrectomy in the treatment of diabetic tractional retinal detachments. Arch Ophthalmol. 2011;129(3):352–5.

    Article  PubMed  Google Scholar 

  43. Grigorian RA, Castellarin A, Fegan R, Seery C, Del Priore LV, Von Hagen S, et al. Epiretinal membrane removal in diabetic eyes: comparison of viscodissection with conventional methods of membrane peeling. Br J Ophthalmol. 2003;87(6):737–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Imamura Y, Minami M, Ueki M, Satoh B, Ikeda T. Use of perfluorocarbon liquid during vitrectomy for severe proliferative diabetic retinopathy. Br J Ophthalmol. 2003;87(5):563–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Barzideh N, Johnson TM. Subfoveal fluid resolves slowly after pars plana vitrectomy for tractional retinal detachment secondary to proliferative diabetic retinopathy. Retina. 2007;27(6):740–3.

    Article  PubMed  Google Scholar 

  46. Tao Y, Jiang YR, Li XX, Gao L, Jonas JB. Long-term results of vitrectomy without endotamponade in proliferative diabetic retinopathy with tractional retinal detachment. Retina. 2010;30(3):447–51.

    Article  PubMed  Google Scholar 

  47. Lewis H, Abrams GW, Williams GA. Anterior hyaloidal fibrovascular proliferation after diabetic vitrectomy. Am J Ophthalmol. 1987;104(6):607–13.

    Article  CAS  PubMed  Google Scholar 

  48. Liggett PE, Lean JS, Barlow WE, Ryan SJ. Intraoperative argon endophotocoagulation for recurrent vitreous hemorrhage after vitrectomy for diabetic retinopathy. Am J Ophthalmol. 1987;103(2):146–9.

    Article  CAS  PubMed  Google Scholar 

  49. Oyakawa RT, Schachat AP, Michels RG, Rice TA. Complications of vitreous surgery for diabetic retinopathy. I. Intraoperative complications. Ophthalmology. 1983;90(5):517–21.

    Article  CAS  PubMed  Google Scholar 

  50. Aaberg TM, Abrams GW. Changing indications and techniques for vitrectomy in management of complications of diabetic retinopathy. Ophthalmology. 1987;94(7):775–9.

    Article  CAS  PubMed  Google Scholar 

  51. Carter JB, Michels RG, Glaser BM, De Bustros S. Iatrogenic retinal breaks complicating pars plana vitrectomy. Ophthalmology. 1990;97(7):848–53; discussion 54.

    Article  CAS  PubMed  Google Scholar 

  52. Mirza SA, Alexandridou A, Marshall T, Stavrou P. Surgically induced miosis during phacoemulsification in patients with diabetes mellitus. Eye (Lond). 2003;17(2):194–9.

    Article  CAS  Google Scholar 

  53. Ubuka M, Sugiyama T, Onoda Y, Shiba T, Hori Y, Maeno T. Changes in the blood flow of the optic nerve head induced by different concentrations of epinephrine in intravitreal infusion during vitreous surgery. Invest Ophthalmol Vis Sci. 2014;55(3):1625–9.

    Article  CAS  PubMed  Google Scholar 

  54. Eaton AM, Jaffe GJ, McCuen BW 2nd, Mincey GJ. Condensation on the posterior surface of silicone intraocular lenses during fluid-air exchange. Ophthalmology. 1995;102(5):733–6.

    Article  CAS  PubMed  Google Scholar 

  55. Chandra A, **ng W, Kadhim MR, Williamson TH. Suprachoroidal hemorrhage in pars plana vitrectomy: risk factors and outcomes over 10 years. Ophthalmology. 2014;121(1):311–7.

    Article  PubMed  Google Scholar 

  56. Sharma T, Virdi DS, Parikh S, Gopal L, Badrinath SS, Mukesh BN. A case-control study of suprachoroidal hemorrhage during pars plana vitrectomy. Ophthalmic Surg Lasers. 1997;28(8):640–4.

    Article  CAS  PubMed  Google Scholar 

  57. Sukpen I, Stewart JM. Acute intraoperative suprachoroidal hemorrhage during small-gauge pars plana vitrectomy. Retin Cases Brief Rep. 2018;12(Suppl 1):S9–S11.

    Article  PubMed  Google Scholar 

  58. Tabandeh H, Sullivan PM, Smahliuk P, Flynn HW Jr, Schiffman J. Suprachoroidal hemorrhage during pars plana vitrectomy. Risk factors and outcomes. Ophthalmology. 1999;106(2):236–42.

    Article  CAS  PubMed  Google Scholar 

  59. Charles S, Randolph JC, Sigler EJ. Pars plana vitrectomy reoperation without removing silicone oil. Retina. 2012;32(8):1664–5.

    Article  PubMed  Google Scholar 

  60. Tolentino FI, Cajita VN, Gancayco T, Skates S. Vitreous hemorrhage after closed vitrectomy for proliferative diabetic retinopathy. Ophthalmology. 1989;96(10):1495–500.

    Article  CAS  PubMed  Google Scholar 

  61. Schachat AP, Oyakawa RT, Michels RG, Rice TA. Complications of vitreous surgery for diabetic retinopathy. II. Postoperative complications. Ophthalmology. 1983;90(5):522–30.

    Article  CAS  PubMed  Google Scholar 

  62. Khuthaila MK, Hsu J, Chiang A, DeCroos FC, Milder EA, Setlur V, et al. Postoperative vitreous hemorrhage after diabetic 23-gauge pars plana vitrectomy. Am J Ophthalmol. 2013;155(4):757–63, e1–2.

    Article  PubMed  Google Scholar 

  63. Lee BJ, Yu HG. Vitreous hemorrhage after the 25-gauge transconjunctival sutureless vitrectomy for proliferative diabetic retinopathy. Retina. 2010;30(10):1671–7.

    Article  PubMed  Google Scholar 

  64. Novak MA, Rice TA, Michels RG, Auer C. Vitreous hemorrhage after vitrectomy for diabetic retinopathy. Ophthalmology. 1984;91(12):1485–9.

    Article  CAS  PubMed  Google Scholar 

  65. Steel DH, Habib MS, Park S, Hildreth AJ, Owen RI. Entry site neovascularization and vitreous cavity hemorrhage after diabetic vitrectomy. The predictive value of inner sclerostomy site ultrasonography. Ophthalmology. 2008;115(3):525–32.

    Article  CAS  PubMed  Google Scholar 

  66. Virata SR, Kylstra JA. Postoperative complications following vitrectomy for proliferative diabetic retinopathy with sew-on and noncontact wide-angle viewing lenses. Ophthalmic Surg Lasers. 2001;32(3):193–7.

    Article  CAS  PubMed  Google Scholar 

  67. Brown GC, Tasman WS, Benson WE, McNamara JA, Eagle RC Jr. Reoperation following diabetic vitrectomy. Arch Ophthalmol. 1992;110(4):506–10.

    Article  CAS  PubMed  Google Scholar 

  68. Cooper B, Shah GK, Grand MG, Bakal J, Sharma S. Visual outcomes and complications after multiple vitrectomies for diabetic vitreous hemorrhage. Retina. 2004;24(1):19–22.

    Article  PubMed  Google Scholar 

  69. Cheema RA, Mushtaq J, Al-Khars W, Al-Askar E, Cheema MA. Role of intravitreal bevacizumab (Avastin) injected at the end of diabetic vitrectomy in preventing postoperative recurrent vitreous hemorrhage. Retina. 2010;30(10):1646–50.

    Article  PubMed  Google Scholar 

  70. Hershberger VS, Augsburger JJ, Hutchins RK, Raymond LA, Krug S. Fibrovascular ingrowth at sclerotomy sites in vitrectomized diabetic eyes with recurrent vitreous hemorrhage: ultrasound biomicroscopy findings. Ophthalmology. 2004;111(6):1215–21.

    Article  PubMed  Google Scholar 

  71. Chang S. LXII Edward Jackson lecture: open angle glaucoma after vitrectomy. Am J Ophthalmol. 2006;141(6):1033–43.

    Article  PubMed  Google Scholar 

  72. Kim BZ, Lee KL, Guest SJ, Worsley D. Long-term survival following diabetic vitrectomy. N Z Med J. 2017;130(1450):69–77.

    PubMed  Google Scholar 

  73. Helbig H, Kellner U, Bornfeld N, Foerster MH. Life expectancy of diabetic patients undergoing vitreous surgery. Br J Ophthalmol. 1996;80(7):640–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Gollamudi SR, Smiddy WE, Schachat AP, Michels RG, Vitale S. Long-term survival rate after vitreous surgery for complications of diabetic retinopathy. Ophthalmology. 1991;98(1):18–22.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Retina Institute, St. Louis, MO, USA

    Vishal S. Parikh, Kevin J. Blinder & M. Gilbert Grand

Authors
  1. Vishal S. Parikh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kevin J. Blinder
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Gilbert Grand
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Ophthalmology, Oregon Health & Science University Department of Ophthalmology, Portland, OR, USA

    Daniel Albert

  2. Massachusetts Eye and Ear, Boston, MA, USA

    Joan Miller

  3. Department of Ophthalmology, University of Illinois at Chicago Department of Ophthalmology, Chicago, IL, USA

    Dimitri Azar

  4. Department of Ophthalmology, Harvard Medical School, Boston, MA, USA

    Lucy H. Young

Section Editor information

  1. Massachusetts Eye and Ear, Boston, USA

    Dean Eliott

  2. Massachusetts Eye and Ear, Boston, USA

    Demetrios Vavvas

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Parikh, V.S., Blinder, K.J., Grand, M.G. (2021). Surgical Management of Proliferative Diabetic Retinopathy. In: Albert, D., Miller, J., Azar, D., Young, L.H. (eds) Albert and Jakobiec's Principles and Practice of Ophthalmology. Springer, Cham. https://doi.org/10.1007/978-3-319-90495-5_107-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90495-5_107-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90495-5

  • Online ISBN: 978-3-319-90495-5

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation